Insights about U.S. Stocks that landed in the Red-Zone during Tuesday’s trade, are depicted underneath:
Smith & Wesson Holding Corp (NASDAQ:SWHC)’s shares dwindled -4.33%, and closed at $ 13.05, during the last trading session.
Smith & Wesson Holding Corporation (SWHC), a leader in firearm manufacturing and design, declared financial results for the fiscal 2015 third quarter ended January 31, 2015.
Third Quarter Fiscal 2015 Financial Highlights:
- Total net sales for the third quarter were $130.6 million, a decrease of 10.5% from net sales of $145.9 million for the third quarter last year. Proceed exceeded the high end of the corporation’s stated guidance range as a result of order strength from distributors and key retailers in January 2015.
- Firearm division net sales for the third quarter totaled $124.5 million, a decrease of 14.7% from the comparable quarter last year. The corporation believes that during the quarter a portion of the consumer demand for handguns and long guns was satisfied with excess industry channel inventory. Accordingly, net sales of the corporation’s handguns declined $6.8 million, or 6.8%, and net sales of the corporation’s long guns declined $13.5 million, or 39.8%, from the comparable quarter last year.
- Accessories division net sales for the third quarter were $6.1 million, or 4.6% of total net sales. The corporation’s accessories division is comprised entirely of Battenfeld Technologies, Inc. (BTI), which was attained on December 11, 2014. Therefore, accessories division net sales reflect only a partial quarter of proceed.
Smith & Wesson Holding Corporation manufactures and sells firearm products in the United States and internationally. It offers firearms; handguns, counting revolvers and pistols; long guns, such as sporting, bolt action, and single shot rifles; hunting rifles; black powder firearms; handcuffs and restraints; and firearm-related products and accessories.
MedAssets, Inc (NASDAQ:MDAS), declined -4.25%, and closed at $18.49.
MedAssets, Inc. (MDAS), declared that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2015 in Miami. The corporation’s formal presentation is planned for 2:05 pm ET, and its administration team will host investor meetings throughout the day in conjunction with the conference.
MedAssets, Inc., a financial and performance improvement corporation, provides technology-enabled products and services for hospitals, health systems, and other ancillary healthcare providers in the United States.
Integrated Device Technology Inc (NASDAQ:IDTI), dipped -4.24%, and closed at $20.31.
Integrated Device Technology, Inc. (IDTI), introduced a new wireless power receiver that delivers faster charging in an ultra-compact form factor. The P9027 magnetic induction receiver offers 80 percent peak system level efficiency and improved overall thermal performance. The high-efficiency architecture enables higher power transfer rates, translating into shorter charge times for portable devices such as smart phones and phablets. Supporting the Wireless Power Consortium’s Qi standard, the P9027 is an 8 Watt receiver featuring an ultra compact solution size—about 37 square millimeters—and requiring six fewer capacitors than competitive products. The result is less board space and a lower bill of materials cost.
The device’s proprietary alignment guide optimizes inductive coupling with the transmitter to maximize coil-to-coil power efficiency. The 3 V to 7 V adjustable output voltage range is capable of driving a variety of downstream power administration ICs, while proprietary foreign object detection (FOD) ensures safe operation in the presence of metal objects.
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of mixed signal semiconductor solutions for the communications, computing, and consumer industries worldwide.
Mylan Inc (NASDAQ:MYL) dropped -4.24%, and closed at $55.44.
Mylan, Inc. (MYL), declared the commencement of consent solicitations regarding Mylan’s 3.750% Cash Convertible Notes due 2015, 7.875% Senior Notes due 2020, 3.125% Senior Notes due 2023, 1.800% Senior Notes due 2016, 2.600% Senior Notes due 2018, 1.350% Senior Notes due 2016, 2.550% Senior Notes due 2019, 4.200% Senior Notes due 2023 and 5.400% Senior Notes due 2043.
As formerly declared on Feb. 27, 2015, the Companies consummated the transactions contemplated by the Amended and Restated Business Transfer Contract and Plan of Merger, dated as of Nov. 4, 2014, between and among Abbott Laboratories, an Illinois corporation, Mylan, the Parent, and Moon of PA Inc., a Pennsylvania corporation, as a result of which Mylan became a wholly-owned indirect partner of the Parent and the Parent attained Abbott’s non-U.S. developed markets specialty and branded generics business. In addition, on Feb. 27, 2015, the Parent fully and unconditionally guaranteed each series of Notes.
Mylan Inc., a pharmaceutical corporation, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide.
